Royalty Pharma plc
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $16.38B
Liabilities Breakdown FY2023
Total Liabilities: $6.30B
Asset Breakdown
Total Assets: $16.38B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $477.0M | 2.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $15.90B | 97.1% |
Liabilities Breakdown
Total Liabilities: $6.30B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $6.14B | 97.4% |
| Other Liabilities | $162.3M | 2.6% |